Furthermore, pharmacological stimulation of circadian clock components REV-ERBs, which repress transcription of CLOCK as well as BMAL1, was capable of inhibiting the growth of GBM (Figure 5 and Table 1) [10, 195]. The gene discussed is BMAL1; the disease is glioblastoma.